Introducing molecular testing of pyrazinamide susceptibility improves multidrug-resistant tuberculosis treatment outcomes: a prospective cohort study | |
Guan, Wenlong; Sun, Feng; Li, Yang; Chen, Yu; Jiang, Xiangao; Wang, Xiaomeng; Ren, Pengfei; Li, Junlian; Shi, Jichan; He, Guiqing | |
刊名 | EUROPEAN RESPIRATORY JOURNAL |
2019 | |
卷号 | 53期号:3 |
ISSN号 | 0903-1936 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3595173 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Guan, Wenlong,Sun, Feng,Li, Yang,et al. Introducing molecular testing of pyrazinamide susceptibility improves multidrug-resistant tuberculosis treatment outcomes: a prospective cohort study[J]. EUROPEAN RESPIRATORY JOURNAL,2019,53(3). |
APA | Guan, Wenlong.,Sun, Feng.,Li, Yang.,Chen, Yu.,Jiang, Xiangao.,...&Zhang, Wenhong.(2019).Introducing molecular testing of pyrazinamide susceptibility improves multidrug-resistant tuberculosis treatment outcomes: a prospective cohort study.EUROPEAN RESPIRATORY JOURNAL,53(3). |
MLA | Guan, Wenlong,et al."Introducing molecular testing of pyrazinamide susceptibility improves multidrug-resistant tuberculosis treatment outcomes: a prospective cohort study".EUROPEAN RESPIRATORY JOURNAL 53.3(2019). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论